MORRIS GABRIEL S (Chief Financial Officer) purchased 0.3% of their position (770.00 shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $5.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/10/2025ACC: 0001493152-25-027107
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+770.00
Net shares
Net buyer
$129.9K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
156.77K acquired · 156K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+156K
Price / share
$0.80
Trade value
$124.80K
% of position
57.6%
12/8/2025
270.84K→426.84K
Common Stock
Direct
Shares
+770.00
Price / share
$6.58
Trade value
$5.07K
% of position
0.3%
12/10/2025
290.66K→291.43K
Total
Net shares
+156.77K
Net value
$129.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/8/2025 | X · X | +156K | $0.80 | $124.80K | 57.6% | 270.84K | 426.84K |
| Common Stock Direct | 12/10/2025 | P · Purchase | +770.00 | $6.58 | $5.07K | 0.3% | 290.66K | 291.43K |
| Total | +156.77K | $129.87K | ||||||
Derivative Transactions2
Warrants (right to purchase)
Indirect
Converts to
Common stock
96K shares
Shares
−96K
Strike price
0.8
Held after
0.00
Exercisable
—
12/8/2025
Warrants (right to purchase)
Indirect
Converts to
Common stock
60K shares
Shares
−60K
Strike price
0.8
Held after
0.00
Exercisable
—
12/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to purchase) Indirect | Common stock96K shares | 12/8/2025 | X · X | −96K | 0.8 | — | 0.00 |
| Warrants (right to purchase) Indirect | Common stock60K shares | 12/8/2025 | X · X | −60K | 0.8 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned24.14K
Total
24.14K indirect24.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 24.14K | Indirect |
| Total | 24.14K | 24.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported